Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)

ClinicalTrials.gov ID: NCT01969708

Public ClinicalTrials.gov record NCT01969708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 9:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study of COmparative Treatments for REtinal Vein Occlusion 2 [SCORE2]: a Multicenter, Prospective, Randomized Non-inferiority Trial of Eyes With Macular Edema Secondary to Central Retinal Vein Occlusion, Comparing Intravitreal Bevacizumab Every 4 Weeks With Intravitreal Aflibercept Every 4 Weeks.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

SCORE2 is a multicenter, prospective, randomized, phase III clinical trial in which all participants enrolled will be followed for up to 2.5 years. SCORE2 is designed as a non-inferiority trial, with study eyes randomized to intravitreal bevacizumab (1.25 mg) every 4 weeks vs. intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema associated with central retinal vein occlusion (CRVO), with the primary outcome of visual acuity measured at Month 6.

Study identification

NCT ID
NCT01969708
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
The Emmes Company, LLC
Industry
Enrollment
362 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2014 (Actual)
Primary completion
Nov 2016 (Actual)
Completion
Mar 2021 (Actual)
Last update posted
Jun 22, 2021

2014 – 2021

United States locations

U.S. sites
72
U.S. states
28
U.S. cities
63
Facility City State ZIP Site status
Retinal Consultants of AZ Phoenix Arizona 85014 —
Retina Centers, P.C. Tucson Arizona 85704 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
East Bay Retina Consultants, Inc. Oakland California 94609 —
Southern California Desert Retina Consultants Palm Desert California 92211 —
University of California Davis, Medical Center Sacramento California 95817 —
Retinal Consultants Medical Group, Inc. Sacramento California 95819 —
University of California, San Francisco San Francisco California 94143 —
New England Retina Associates New London Connecticut 06320 —
Retina Group of Florida Fort Lauderdale Florida 33308 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
University of Florida, Dept of Ophthalmology Jacksonville Florida 32209 —
Florida Retina Consultants Lakeland Florida 33805 —
Sarasota Retina Institute Sarasota Florida 34239 —
Center for Retina and Macular Disease Winter Haven Florida 33880 —
Florida Retina Consultants Winter Haven Florida 33880 —
Emory University Eye Center Atlanta Georgia 30322 —
Southeast Retina Center Augusta Georgia 30909 —
Georgia Retina, P.C. Marietta Georgia 30060 —
Illinois Eye and Ear Infirmary UIC Dept. of Ophthalmology Chicago Illinois 60612 —
Thomas A. Ciulla, MD, PC Indianapolis Indiana 46290 —
Sabates Eye Centers Leawood Kansas 66211 —
Retina Associates, PA Shawnee Mission Kansas 66204 —
Retina Associates of Kentucky Lexington Kentucky 40509 —
University of Kentucky Lexington Kentucky 40536 —
Paducah Retinal Center Paducah Kentucky 42001 —
Elman Retina Group, PA Baltimore Maryland 21237 —
The Retina Group of Washington Chevy Chase Maryland 20815 —
Elman Retina Group, P.A. Glen Burnie Maryland 21061 —
Cumberland Valley Retina Consultants Hagerstown Maryland 21740 —
Elman Retina Group, P.A. Pikesville Maryland 21208 —
Henry Ford Health System Detroit Michigan 48202 —
TLC Eyecare & Laser Centers Jackson Michigan 49202 —
VitreoRetinal Surgery Minneapolis Minnesota 55435 —
Mayo Clinic Rochester Minnesota 55905 —
The Retina Institute St Louis Missouri 63128 —
UNMC Truhlsen Eye Institute Omaha Nebraska 68198 —
Retina Consultants of Nevada Las Vegas Nevada 89144 —
Delaware Valley Retina Associates Lawrenceville New Jersey 08648 —
NJ Retina New Brunswick New Jersey 08901 —
New York Eye and Ear Infirmary New York New York 10003 —
Retina Associates of Western New York Rochester New York 14620 —
University of Rochester Flaum Eye Institute Rochester New York 14642 —
Retina Vitreous Surgeon of CNY, PC Syracuse New York 13224 —
Charlotte Eye Ear Nose & Throat Associates, P.A. Charlotte North Carolina 28210 —
Charlotte Eye Ear Nose & Throat Associates, P.A. Statesville North Carolina 28677 —
Retina Associates of Cleveland, Inc. Cleveland Ohio 44122 —
The Ohio State University Columbus Ohio 43212 —
Dean McGee Eye Institute Oklahoma City Oklahoma 73104 —
Retina Northwest, PC Portland Oregon 97210 —
Casey Eye Institute / OHSU Portland Oregon 97239 —
Retina Vitreous Consultants Monroeville Pennsylvania 15146 —
Scheie Eye Institute Philadelphia Pennsylvania 19104 —
Carolinas Centers for Sight, PC Florence South Carolina 29501 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Southeastern Retina Associates, PC Knoxville Tennessee 37909 —
Tennessee Retina, PC Nashville Tennessee 37203 —
Vanderbilt Eye Institute Nashville Tennessee 37232-8808 —
Retina Research Institute of Texas Abilene Texas 79606 —
Texas Retina Associates Arlington Texas 76012 —
The Retina Research Center Austin Texas 78705 —
Texas Retina Associates Dallas Texas 75231 —
Charlotte Eye Ear Nose & Throat Associates, P.A. Houston Texas 77025 —
Retina & Vitreous of Texas Houston Texas 77025 —
Retina Consultants of Houston, PA Houston Texas 77030 —
Valley Retina Institute, PA McAllen Texas 78503 —
Medical Center Ophthalmology Associates San Antonio Texas 78240 —
Retinal Consultants of San Antonio San Antonio Texas 78240 —
The Retina Group of Washington Fairfax Virginia 22031 —
University of Wisconsin Madison Wisconsin 53705 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01969708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2021 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01969708 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →